Neoproteoglycans in tissue engineering

FEBS Journal

Volumn 280, Issue 10, 2013, Pages 2511-2522

  Weyers, Amanda ^a   Linhardt, Robert J ^a,b  

^a Research Rensselaer Polytechnic Institute   (United States)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

biomedical scaffolds; extracellular matrix; glycoconjugates; glycosaminoglycans; growth factors; nanocomposites; neoproteoglycans; proteoglycans; regenerative medicine; tissue engineering

Indexed keywords

CARBON NANOTUBE; CHONDROITIN SULFATE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; GOLD NANOPARTICLE; HYALURONIC ACID; LOW MOLECULAR WEIGHT HEPARIN; NANOMATERIAL; NEOPROTEOGLYCAN; POLYGLACTIN; POLYLACTIC ACID; POLYMER; POLYVINYL ALCOHOL; PROTEOGLYCAN; SILVER NANOPARTICLE; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; BIOCOMPATIBILITY; BIODEGRADABILITY; CELL GROWTH; CHONDROGENESIS; CONJUGATION; ELECTROSPINNING; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; TISSUE REGENERATION; WOUND HEALING;

ANIMALS; BIOMIMETIC MATERIALS; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS; HEPARIN; HUMANS; HYDROGEL; MACROMOLECULAR SUBSTANCES; NANOCOMPOSITES; NANOPARTICLES; PROTEIN BINDING; PROTEOGLYCANS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84877687026     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12187     Document Type: Review

References (96)

1. Langer R, &, Vacanti JP, (1993) Tissue engineering. Science 260, 920-926. (Pubitemid 23209960)
2. Ma PX, (2008) Biomimetic materials for tissue engineering. Adv Drug Deliv Rev 60, 184-198. (Pubitemid 350245692)
3. Yang F, Neeley WL, Moore MJ, Karp JM, Shukla A, &, Langer R, (2008) Tissue engineering: the therapeutic strategy of the twenty-first century. In Nanotechnology and Tissue Engineering The Scaffold Based Approach (, Laurencin CT, &, Nair LS, eds), pp. 1-65. Wiley-VCH Verlag, Weinheim.
4. Caplan A, (2007) Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213, 341-347. (Pubitemid 47509711)
5. Chen FH, Rousche KT, &, Tuan RS, (2006) Technology insight: adult stem cells in cartilage regeneration and tissue engineering. Nat Clin Pract Rheumatol 2, 373-382.
6. Urban JP, Hall AC, &, Gehl KA, (1993) Regulation of matrix synthesis rates by the ionic and osmotic environment of articular chondrocytes. J Cell Physiol 154, 262-270. (Pubitemid 23048006)
7. Scott JE, (1995) Extracellular matrix, supramolecular organisation and shape. J Anat 187, 259-269.
8. Rosso F, Giordano A, Barbarisi M, &, Barbarisi A, (2004) From cell-ECM interactions to tissue engineering. J Cell Physiol 199, 174-180. (Pubitemid 38436743)
9. Badylak SF, (2007) The extracellular matrix as a biologic scaffold material. Biomaterials 28, 3587-3593. (Pubitemid 46855878)
10. Zhong S, Teo WE, Zhu X, Beuerman R, Ramakrishna S, &, Yung LYL, (2005) Formation of collagen-glycosaminoglycan blended nanofibrous scaffolds and their biological properties. Biomacromolecules 6, 2998-3004. (Pubitemid 41764054)
11. Casper CL, Yang W, Farach-Carson MC, &, Rabolt JF, (2007) Coating electrospun collagen and gelatin fibers with perlecan domain I for increased growth factor binding. Biomacromolecules 8, 1116-1123. (Pubitemid 46672688)
12. Rosso F, Marino G, Giordano A, Barbarisi M, Parmeggiani D, &, Barbarisi A, (2005) Smart materials as scaffolds for tissue engineering. J Cell Physiol 203, 465-470. (Pubitemid 40629007)
13. Esko JD, Kimata K, &, Lindahl U, (1999) Proteoglycans and glycosaminoglycans. In Essentials of Glycobiology (, Varki A, Cummings R, Esko JD, Freeze HH, Hart G, &, Marth JD, eds), pp. 229-248. Cold Spring Harbor Laboratory Press, New York.
14. Hocking AM, Shinomura T, &, McQuillan DJ, (1998) Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol 17, 1-19. (Pubitemid 28206020)
15. Mäkelä JT, Huttu MRJ, &, Korhonen RK, (2012) Structure-function relationships in osteoarthritic human hip joint articular cartilage. Osteoarthritis Cartilage 20, 1268-1277.
16. Kresse H, &, Schönherr E, (2001) Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 189, 266-274. (Pubitemid 33063294)
17. Yanagishita M, (1993) Function of proteoglycans in the extracellular matrix. Pathol Int 43, 283-293. (Pubitemid 23174979)
18. Iozzo RV, &, Karamanos N, (2010) Proteoglycans in health and disease: emerging concepts and future directions. FEBS J 277, 3863.
19. Theocharis AD, Skandalis SS, Tzanakakis GN, &, Karamanos NK, (2010) Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J 277, 3904-3923.
20. Ferdous Z, &, Grande-Allen KJ, (2007) Utility and control of proteoglycans in tissue engineering. Tissue Eng 13, 1893-1904. (Pubitemid 47293989)
21. Ricardo P, Mulloy B, &, Mourão P, (1991) Structure of a fucose-branched chondroitin sulfate from sea cucumber. J Biol Chem 266, 13530-13536.
22. Gao C-X, Miyoshi E, Uozumi N, Takamiya R, Wang X, Noda K, Gu J, Honke K, Wada Y, &, Taniguchi N, (2005) Bisecting GlcNAc mediates the binding of annexin V to Hsp47. Glycobiology 15, 1067-1075. (Pubitemid 41662633)
23. Linhardt RJ, &, Toida T, (2004) Role of glycosaminoglycans in cellular communication. Acc Chem Res 37, 431-438.
24. Gandhi NS, &, Mancera RL, (2008) The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Design 72, 455-482.
25. Toida T, Amornrut C, &, Linhardt R, (2003) Structure and bioactivity of sulfated polysaccharides. Trends Glycosci Glycotechnol 15, 29-46. (Pubitemid 36928473)
26. Capila I, &, Linhardt RJ, (2002) Heparin-protein interactions. Angew Chemie 41, 391-412.
27. Li L, Ly M, &, Linhardt RJ, (2012) Proteoglycan sequence. Mol BioSyst 8, 1613-1625.
28. Laremore TN, Ly M, Zhang Z, Solakyildirim K, McCallum SA, Owens RT, &, Linhardt RJ, (2010) Domain structure elucidation of human decorin glycosaminoglycans. Biochem J 431, 199-205.
29. Li L, Zhang F, Zaia J, &, Linhardt RJ, (2012) Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS. Anal Chem 84, 8822-8829.
30. Ly M, Leach FE, Laremore TN, Toida T, Amster IJ, &, Linhardt RJ, (2011) The proteoglycan bikunin has a defined sequence. Nat Chem Biol 7, 827-833.
31. Fransson L-A, (2003) Glypicans. Int J Biochem Cell Biol 35, 125-129. (Pubitemid 35446318)
32. Guido D, (1993) Integral membrane heparan sulfate proteoglycans. FEBS J 7, 1023-1030.
33. Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, &, Iozzo RV, (1997) Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 136, 729-743. (Pubitemid 27083772)
34. Pogány G, &, Vogel KG, (1992) The interaction of decorin core protein fragments with type I collagen. Biochem Biophys Res Commun 189, 165-172. (Pubitemid 23030022)
35. Orgel JPRO, Eid A, Antipova O, Bella J, &, Scott JE, (2009) Decorin core protein (decoron) shape complements collagen fibril surface structure and mediates its binding. PLoS One 4, 10.
36. Galli SJ, Tsai M, &, Piliponsky AM, (2008) The development of allergic inflammation. Nature 454, 445-454.
37. Kolset SO, &, Tveit H, (2008) Serglycin-structure and biology. Cell Mol Life Sci 65, 1073-1085.
38. Ellis AL, Pan W, Yang G, Jones K, Chuang C, Whitelock JM, &, DeCarlo AA, (2010) Similarity of recombinant human perlecan domain 1 by alternative expression systems bioactive heterogenous recombinant human perlecan D1. BMC Biotechnol 10, 66.
39. Costell M, Mann K, Yamada Y, &, Timpl R, (1997) Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides. Eur J Biochem 243, 115-121. (Pubitemid 27060392)
40. Whitelock J, Ma J, Davies N, Nielsen N, Chuang C, Rees M, Iozzo RV, Knox S, &, Lord M, (2008) Recombinant heparan sulfate for use in tissue engineering applications. J Chem Technol Biotechnol 83, 496-504. (Pubitemid 351460913)
41. Seyfried NT, McVey GF, Almond A, Mahoney DJ, Dudhia J, &, Day AJ, (2005) Expression and purification of functionally active hyaluronan-binding domains from human cartilage link protein, aggrecan and versican: formation of ternary complexes with defined hyaluronan oligosaccharides. J Biol Chem 280, 5435-5448. (Pubitemid 40280019)
42. Retzler C, Wiedemann H, Kulbe G, &, Rauch U, (1996) Structural and electron microscopic analysis of neurocan and recombinant neurocan fragments. J Biol Chem 271, 17107-17113. (Pubitemid 26244259)
43. Ramamurthy P, Hocking AM, &, Mcquillan DJ, (1996) Recombinant decorin glycoforms. JBiolChem 271, 19578-19584.
44. Hocking AM, Strugnell RA, Ramamurthy P, &, Mcquillan DJ, (1996) Eukaryotic expression of recombinant biglycan. J Biol Chem 271, 19571-19577.
45. Zheng Z, Jian J, Zhang X, Zara JN, Yin W, Chiang M, Liu Y, Wang J, Pang S, Ting K, et al,. (2012) Reprogramming of human fibroblasts into multipotent cells with a single ECM proteoglycan, fibromodulin. Biomaterials 33, 5821-5831.
46. Yang WD, Gomes RR, Alicknavitch M, Farach-Carson MC, &, Carson DD, (2005) Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds. Tissue Eng 11, 76-89. (Pubitemid 40515177)
47. Yang W, Gomes RR, Brown AJ, Burdett AR, Alicknavitch M, Farach-Carson MC, &, Carson DD, (2006) Chondrogenic differentiation on perlecan domain I, collagen II, and bone morphogenetic protein-2-based matrices. Tissue Eng 12, 2009-2024. (Pubitemid 44162858)
48. Nel A, Xia T, Mädler L, &, Li N, (2006) Toxic potential of materials at the nanolevel. Science 311, 622-627. (Pubitemid 43191298)
49. Kunzmann A, Andersson B, Thurnherr T, Krug H, Scheynius A, &, Fadeel B, (2011) Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta 1810, 361-373.
50. Chinol M, Casalini P, Maggiolo M, Canevari S, Omodeo ES, Caliceti P, Veronese FM, Cremonesi M, Chiolerio F, Nardone E, et al,. (2006) Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity. Br J Cancer 78, 189-197.
51. Ratner BD, (2002) Reducing capsular thickness and enhancing angiogenesis around implant drug release systems. J Control Release 78, 211-218. (Pubitemid 34081866)
52. Goldberg M, Langer R, &, Jia X, (2007) Nanostructured materials for applications in drug delivery and tissue engineering. J Biomat Sci Polym Ed 18, 241-268. (Pubitemid 46403135)
53. Paderi JE, Sistiabudi R, Ivanisevic A, &, Panitch A, (2009) Collagen-binding peptidoglycans: a biomimetic approach to modulate collagen fibrillogenesis for tissue engineering applications. Tissue Eng 15, 2991-2999.
54. Pumphrey CY, Theus AM, Li S, Parrish RS, &, Sanderson RD, (2002) Neoglycans, carbodiimide-modified glycosaminoglycans: a new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis. Cancer Res 62, 3722-3728. (Pubitemid 34728853)
55. Wang D-A, Varghese S, Sharma B, Strehin I, Fermanian S, Gorham J, Fairbrother DH, Cascio B, &, Elisseeff JH, (2007) Multifunctional chondroitin sulphate for cartilage tissue-biomaterial integration. Nat Mat 6, 385-392. (Pubitemid 46693196)
56. Caliari SR, &, Harley BC, (2011) The effect of anisotropic collagen-GAG scaffolds and growth factor supplementation on tendon cell recruitment, alignment, and metabolic activity. Biomaterials 32, 5330-5340.
57. Dimitrellos V, Lamari FN, Militsopoulou M, Kanakis I, &, Karamanos NK, (2003) Capillary electrophoresis and enzyme solid phase assay for examining the purity of a synthetic heparin proteoglycan-like conjugate and identifying binding to basic fibroblast growth factor. Biomed Chromatogr 17, 42-47. (Pubitemid 36240668)
58. Kuberan B, Gunay N, Dordick J, &, Linhardt R, (1999) Preparation and isolation of neoglycoconjugates using biotin-streptavidin complexes. Glycoconj J 16, 271-281. (Pubitemid 29486315)
59. Lee SS, Brown JJM, Rogers CJC, Matson JB, Krishnamurthy C, Rawat M, &, Hsieh-Wilson LC, (2010) End-functionalized glycopolymers as mimetics of chondroitin sulfate proteoglycans. Chem Sci 1, 322-325.
60. Merrett K, Liu W, Mitra D, Camm KD, McLaughlin CR, Liu Y, Watsky M, Li F, Griffith M, &, Fogg DE, (2009) Synthetic neoglycopolymer-recombinant human collagen hybrids as biomimetic crosslinking agents in corneal tissue engineering. Biomaterials 30, 5403-5408.
61. Liu H, Wang L, Brock A, Wong C-H, &, Schultz PG, (2003) A method for the generation of glycoprotein mimetics. J Am Chem Soc 125, 1702-1703. (Pubitemid 36232557)
62. Paderi JE, &, Panitch A, (2008) Design of a synthetic collagen-binding peptidoglycan that modulates collagen fibrillogenesis. Biomacromolecules 9, 2562-2566.
63. Sistiabudi R, Paderi J, Panitch A, &, Ivanisevic A, (2009) Modification of native collagen with cell-adhesive peptide to promote RPE cell attachment on Bruch's membrane. Biotechnol Bioeng 102, 1723-1729.
64. Stuart K, Paderi J, Snyder PW, Freeman L, &, Panitch A, (2011) Collagen-binding peptidoglycans inhibit MMP mediated collagen degradation and reduce dermal scarring. PLoS ONE 6, e22139.
65. Sharma S, Panitch A, &, Neu CP, (2013) Incorporation of an aggrecan mimic prevents proteolytic degradation of anisotropic cartilage analogs. Acta Biomater 9, 4618-4625.
66. Coburn JM, Gibson M, Monagle S, Patterson Z, &, Elisseeff JH, (2012) Bioinspired nanofibers support chondrogenesis for articular cartilage repair. Proc Natl Acad Sci USA 109, 1-6.
67. Lynn AK, Best SM, Cameron RE, Harley BA, Yannas IV, Gibson LJ, &, Bonfield W, (2010) Design of a multiphase osteochondral scaffold. I. Control of chemical composition. J Biomed Mater Res A 92, 1057-1065.
68. Harley BA, Lynn AK, Wissner-Gross Z, Bonfield W, Yannas IV, &, Gibson LJ, (2010) Design of a multiphase osteochondral scaffold. II. Fabrication of a mineralized collagen-glycosaminoglycan scaffold. J Biomed Mater Res A 92, 1066-1077.
69. Harley BA, Lynn AK, Wissner-Gross Z, Bonfield W, Yannas IV, &, Gibson LJ, (2010) Design of a multiphase osteochondral scaffold III: fabrication of layered scaffolds with continuous interfaces. J Biomed Mater Res A 92, 1078-1093.
70. Wen Y, Grøndahl L, Gallego MR, Jorgensen L, Møller EH, &, Nielsen HM, (2012) Delivery of dermatan sulfate from polyelectrolyte complex-containing alginate composite microspheres for tissue regeneration. Biomacromolecules 13, 905-917.
71. Kemp MM, &, Linhardt RJ, (2010) Heparin-based nanoparticles. Nanomed Nanobiotechnol 2, 77-87.
72. Murugesan S, Park T-J, Yang H, Mousa S, &, Linhardt RJ, (2006) Blood compatible carbon nanotubes-nano-based neoproteoglycans. Langmuir 22, 3461-3463. (Pubitemid 43672508)
73. Simmons TJ, Lee S-H, Park T-J, Hashim DP, Ajayan PM, &, Linhardt RJ, (2009) Antiseptic single wall carbon nanotube bandages. Carbon 47, 1561-1564.
74. Simmons TJ, Rivet CJ, Singh G, Beaudet J, Sterner E, Guzman D, Hashim DP, Lee S-H, Qian G, &, Lewis KM, et al,. (2012) Application of carbon nanotubes to wound healing biotechnology. In Nanomaterials for Biomedicine (, Nagarajan R, ed.), pp. 155-174. ACS Symposium Series.
75. Kemp MM, Kumar A, Mousa S, Dyskin E, Yalcin M, Ajayan P, Linhardt RJ, &, Mousa SA, (2009) Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties. Nanotechnology 20, 455104.
76. Kemp MM, Kumar A, Mousa S, Park T-J, Ajayan P, Kubotera N, Mousa SA, &, Linhardt RJ, (2009) Synthesis of gold and silver nanoparticles stabilized with glycosaminoglycans having distinctive biological activities. Biomacromolecule 10, 589-595.
77. Kemp MM, Kumar A, Clement D, Ajayan P, Mousa S, &, Linhardt RJ, (2009) Hyaluronan- and heparin-reduced silver nanoparticle with antimicrobial properties. Nanomedicine 4, 421-429.
78. Lee H, Park K, Park S, &, Min B, (2007) Chitosan/heparin polyelectrolyte complex nanoparticles (100-200 nm) covalently bonded with PEI for enhancement of chondrogenic phenotype. Key Eng Mater 342-343, 329-332. (Pubitemid 46558470)
79. Tan Q, Tang H, Hu J, Hu Y, Zhou X, Tao Y, &, Wu Z, (2011) Controlled release of chitosan/heparin nanoparticle-delivered VEGF enhances regeneration of decellularized tissue-engineered scaffolds. Int J Nanomed 6, 929-942.
80. Hempel U, Möller S, Noack C, Hintze V, Scharnweber D, Schnabelrauch M, &, Dieter P, (2012) Sulfated hyaluronan/collagen I matrices enhance the osteogenic differentiation of human mesenchymal stromal cells in vitro even in the absence of dexamethasone. Acta Biomater 8, 4064-4072.
81. Na K, Kim S, Park K, Kim K, Woo DG, Kwon IC, Chung H-M, &, Park K-H, (2007) Heparin/poly(l -lysine) nanoparticle-coated polymeric microspheres for stem-cell therapy. J Am Chem Soc 129, 5788-5789. (Pubitemid 46748462)
82. Nie T, Akins RE, &, Kiick KL, (2009) Production of heparin-containing hydrogels for modulating cell responses. Acta Biomater 5, 865-875.
83. Freudenberg U, Hermann A, Welzel PB, Stirl K, Schwarz SC, Grimmer M, Zieris A, Panyanuwat W, Zschoche S, Meinhold D, et al,. (2009) A star-PEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases. Biomaterials 30, 5049-5060.
84. Yamaguchi N, &, Kiick KL, (2005) Polysaccharide-poly(ethylene glycol) star copolymer as a scaffold for the production of bioactive hydrogels. Biomacromolecules 6, 1921-1930. (Pubitemid 41052185)
85. Kirker KR, Luo Y, Nielson JH, Shelby J, &, Prestwich GD, (2002) Glycosaminoglycan hydrogel films as bio-interactive dressings for wound healing. Biomaterials 23, 3661-3671. (Pubitemid 34626569)
86. Gilbert ME, Kirker KR, Gray SD, Ward PD, Szakacs JG, Prestwich GD, &, Orlandi RR, (2004) Chondroitin sulfate hydrogel and wound healing in rabbit maxillary sinus mucosa. Laryngoscope 114, 1406-1409. (Pubitemid 39045512)
87. Kirker KR, Luo Y, Morris S, Shelby J, &, Prestwich GD, (2004) Glycosaminoglycan hydrogels as supplemental wound dressings for donor sites. J Burn Care Rehabil 25, 276-286. (Pubitemid 38637786)
88. Sarkar S, Lightfoot-Vidal SE, Schauer CL, Vresilovic E, &, Marcolongo M, (2012) Terminal-end functionalization of chondroitin sulfate for the synthesis of biomimetic proteoglycans. Carbohydr Polym 90, 431-440.
89. Baier Leach J, Bivens KA, Patrick CW, &, Schmidt CE, (2003) Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng 82, 578-589. (Pubitemid 36514267)
90. Burdick JA, &, Prestwich GD, (2011) Hyaluronic acid hydrogels for biomedical applications. Adv Mater 23, H41-H56.
91. Coates EE, Riggin CN, &, Fisher JP, (2012) Matrix molecule influence on chondrocyte phenotype and proteoglycan 4 expression by alginate-embedded zonal chondrocytes and mesenchymal stem cells. J Orthop Res 30, 1886-1897.
92. Rath SN, Pryymachuk G, Bleiziffer OA, Lam CXF, Arkudas A, Ho STB, Beier JP, Horch RE, Hutmacher DW, &, Kneser U, (2011) Hyaluronan-based heparin-incorporated hydrogels for generation of axially vascularized bioartificial bone tissues: in vitro and in vivo evaluation in a PLDLLA-TCP-PCL-composite system. J Mater Sci 22, 1279-1291.
93. Bhakta G, Rai B, Lim ZXH, Hui JH, Stein GS, Van Wijnen AJ, Nurcombe V, Prestwich GD, &, Cool SM, (2012) Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2. Biomaterials 33, 6113-6122.
94. Kuo T-F, Huang A-T, Chang H-H, Lin F-H, Chen S-T, Chen, Rung-ShuChou C-H, Lin H-C, Chiang H, &, Chen M-H, (2008) Regeneration of dentin-pulp complex with cementum and periodontal ligament formation using dental bud cells in gelatin-chondroitin-hyaluronan tri-copolymer scaffold in swine. J Biomed Mater Res A 4, 1062-1068.
95. Chang C-H, Kuo T-F, Lin C-C, Chou C-H, Chen K-H, Lin F-H, &, Liu H-C, (2006) Tissue engineering-based cartilage repair with allogenous chondrocytes and gelatin-chondroitin-hyaluronan tri-copolymer scaffold: a porcine model assessed at 18, 24, and 36 weeks. Biomaterials 27, 1876-1888. (Pubitemid 41759482)
96. Deng T, Huang S, Zhou S, He L, &, Jin Y, (2007) Cartilage regeneration using a novel gelatin-chondroitin-hyaluronan hybrid scaffold containing bFGF-impregnated microspheres. J Microencapsul 24, 163-174. (Pubitemid 46502158)